Transaction #7649 · Form 4 · 0000905148-25-003930
BIODESIX INC · Exercise / conversion · Common Stock
BIODESIX INC · Transacted November 10, 2025 · Filed November 13, 2025
What does this filing report?
An SEC Form 4 filing for BIODESIX INC records an exercise / conversion involving Common Stock on November 10, 2025. The reported quantity was 611. The filing date is November 13, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- BIODESIX INC
- Company CIK
- 0001439725
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 611
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 37,500
- Ownership description
- Not reported
- SEC acceptance time
- Nov 13, 2025, 4:53 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Hutton Scott ↗
President & CEO · Director
CIK 0001697361
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split").
- F2
- Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F3
- Includes 448 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025.
- F4
- These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- F5
- These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.